文献速递泌尿生殖腹部MR

PI-RADS 4或5类前列腺癌患者术后生化失败:根据指数病灶带区位置的风险分层

Postoperative Biochemical Failure in Patients With PI-RADS Category 4 or 5 Prostate Cancers: Risk Stratification According to Zonal Location of an Index Lesion.
PubMed 文献 · AJR Am J Roentgenol · 2020-07-08

回顾性纳入232例PI-RADSv2 4或5类且行根治性前列腺切除术的前列腺癌患者,评估指数病灶带区位置与术后生化失败的关系。2年生化失败无生存率在PI-RADSv2类别间(4类86.4% vs 5类74.5%,p=0.021)及带区间(外周带75.3% vs 移行带96.8%,p=0.003)不同;多因素分析仅MRI指数病灶带区位置与生化失败相关(HR=0.155;p=0.012)。

要点

  • 指数病灶位于外周带者2年生化失败无生存率低于移行带(75.3% vs 96.8%,p=0.003)。
  • PI-RADSv2 5类病灶中,外周带者2年生化失败无生存率低于移行带(62.0% vs 95.0%,p=0.002)。
  • 多因素分析仅MRI指数病灶带区位置与术后生化失败相关(HR=0.155;p=0.012)。

诊断标准与关键数值

  • 生化失败发生于14.2%(33/232)的患者。
  • PI-RADSv2 4或5类指数病灶患者的2年生化失败无生存率为81.3%。
  • 2年生化失败无生存率按PI-RADSv2类别不同:4类86.4% vs 5类74.5%(p=0.021)。
  • 2年生化失败无生存率按带区位置不同:外周带75.3% vs 移行带96.8%(p=0.003)。
  • 4类病灶中,外周带者2年生化失败无生存率83.1% vs 移行带者100.0%(p=0.072);5类病灶中,外周带者62.0% vs 移行带者95.0%(p=0.002)。

临床应用与阅片要点

  • 多因素分析中,仅MRI上指数病灶的带区位置与生化失败相关(风险比=0.155;p=0.012)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The objective of our study was to assess postoperative biochemical failure in patients with prostate cancer according to zonal location of an index lesion classified as Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) category 4 or 5. MATERIALS AND METHODS. Consecutive patients (n = 232) with prostate cancer who had PI-RADSv2 category 4 or 5 lesions on MRI and who underwent radical prostatectomy were retrospectively evaluated. We investigated clinical (prostate-specific antigen density), MRI (PI-RADSv2 category of index lesion and zonal location, assessed as peripheral zone [PZ] or transition zone [TZ], of index lesion), and pathologic (tumor volume, tumor grade, and presence of extraprostatic extension) parameters. We analyzed Kaplan-Meier survival curves and the Cox proportional hazards model to assess 2-year biochemical failure-free survival and identify significant parameters associated with postoperative biochemical failure RESULTS. Biochemical failure occurred in 14.2% of patients (33/232). Two-year biochemical failure-free survival of patients with a PI-RADSv2 category 4 or 5 index lesion was 81.3%. For all patients, 2-year biochemical failure-free survival was different according to PI-RADSv2 category (category 4, 86.4%; category 5, 74.5%; p = 0.021) or zonal location (PZ, 75.3%; TZ, 96.8%; p = 0.003). Two-year biochemical failure-free survival in patients with category 4 lesions was similar in patients with PZ lesions (83.1%) and those with TZ lesions (100.0%) (p = 0.072), whereas it was different in patients with category 5 lesions (PZ, 62.0%; TZ, 95.0%; p = 0.002). In multivariate analysis, only zonal location of an index lesion on MRI was associated with biochemical failure (hazard ratio = 0.155; p = 0.012). CONCLUSION. Zonal location of an index lesion on MRI may be a useful imaging bio-marker to predict postoperative biochemical failure.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Shin N, Park SY. Postoperative Biochemical Failure in Patients With PI-RADS Category 4 or 5 Prostate Cancers: Risk Stratification According to Zonal Location of an Index Lesion. AJR Am J Roentgenol. 2020. PMID: 32755167. doi:10.2214/AJR.19.22653

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。